Target prices for mass production of tyrosine kinase inhibitors for global cancer treatment

OBJECTIVE: To calculate sustainable generic prices for 4 tyrosine kinase inhibitors (TKIs). BACKGROUND: TKIs have proven survival benefits in the treatment of several cancers, including chronic myeloid leukaemia, breast, liver, renal and lung cancer. However, current high prices are a barrier to tre...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMJ Open
Main Authors: Hill, Andrew, Gotham, Dzintars, Fortunak, Joseph, Meldrum, Jonathan, Erbacher, Isabelle, Martin, Manuel, Shoman, Haitham, Levi, Jacob, Powderly, William G, Bower, Mark
Formato: Artigo
Idioma:Inglês
Publicado: BMJ Publishing Group 2016
Assuntos:
Global Health
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4735306/
https://ncbi.nlm.nih.gov/pubmed/26817636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-009586
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares